Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3494 | 1893 | 33.5 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
799 | 11424 | AMYOTROPHIC LATERAL SCLEROSIS//SPINAL MUSCULAR ATROPHY//MOTOR NEURON DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AMYOTROPHIC LATERAL SCLEROSIS | Author keyword | 131 | 15% | 41% | 785 |
2 | AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION | Journal | 41 | 37% | 5% | 88 |
3 | MOTOR NEURON DISEASE | Author keyword | 39 | 16% | 11% | 217 |
4 | MOTOR NEURONE DISEASE | Author keyword | 25 | 34% | 3% | 61 |
5 | ELEANOR LOU GEHRIG MDA ALS | Address | 25 | 55% | 2% | 31 |
6 | ALS | Author keyword | 21 | 11% | 10% | 180 |
7 | ALSAQ 40 | Author keyword | 20 | 100% | 0% | 9 |
8 | ALSFRS R | Author keyword | 13 | 58% | 1% | 15 |
9 | AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS | Journal | 10 | 34% | 1% | 25 |
10 | ALS CLIN | Address | 9 | 34% | 1% | 23 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | AMYOTROPHIC LATERAL SCLEROSIS | 131 | 15% | 41% | 785 | Search AMYOTROPHIC+LATERAL+SCLEROSIS | Search AMYOTROPHIC+LATERAL+SCLEROSIS |
2 | MOTOR NEURON DISEASE | 39 | 16% | 11% | 217 | Search MOTOR+NEURON+DISEASE | Search MOTOR+NEURON+DISEASE |
3 | MOTOR NEURONE DISEASE | 25 | 34% | 3% | 61 | Search MOTOR+NEURONE+DISEASE | Search MOTOR+NEURONE+DISEASE |
4 | ALS | 21 | 11% | 10% | 180 | Search ALS | Search ALS |
5 | ALSAQ 40 | 20 | 100% | 0% | 9 | Search ALSAQ+40 | Search ALSAQ+40 |
6 | ALSFRS R | 13 | 58% | 1% | 15 | Search ALSFRS+R | Search ALSFRS+R |
7 | EL ESCORIAL CRITERIA | 9 | 55% | 1% | 12 | Search EL+ESCORIAL+CRITERIA | Search EL+ESCORIAL+CRITERIA |
8 | ALS MND | 9 | 83% | 0% | 5 | Search ALS+MND | Search ALS+MND |
9 | GOMPERTZIAN ANALYSIS | 6 | 47% | 0% | 9 | Search GOMPERTZIAN+ANALYSIS | Search GOMPERTZIAN+ANALYSIS |
10 | AMYOTROPHIC LATERAL SCLEROSIS FUNCTIONAL RATING SCALE | 4 | 75% | 0% | 3 | Search AMYOTROPHIC+LATERAL+SCLEROSIS+FUNCTIONAL+RATING+SCALE | Search AMYOTROPHIC+LATERAL+SCLEROSIS+FUNCTIONAL+RATING+SCALE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ALS PATIENTS | 115 | 54% | 8% | 146 |
2 | ALS | 99 | 18% | 26% | 496 |
3 | ANTECEDENT EVENTS | 88 | 89% | 2% | 40 |
4 | MOTOR NEURON DISEASE | 82 | 15% | 26% | 495 |
5 | EL ESCORIAL | 64 | 65% | 3% | 61 |
6 | FUNCTIONAL RATING SCALE | 38 | 60% | 2% | 41 |
7 | PRACTICE PARAMETER UPDATE | 29 | 61% | 2% | 31 |
8 | PILOT CASE CONTROL | 26 | 100% | 1% | 11 |
9 | STAGE ALS | 23 | 86% | 1% | 12 |
10 | ALS CLINIC POPULATION | 20 | 100% | 0% | 9 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AMYOTROPHIC LATERAL SCLEROSIS | 94 | 33% | 13% | 238 |
2 | AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION | 41 | 37% | 5% | 88 |
3 | AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS | 10 | 34% | 1% | 25 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Global Epidemiology of Amyotrophic Lateral Sclerosis: A Systematic Review of the Published Literature | 2013 | 33 | 73 | 88% |
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues | 2008 | 144 | 74 | 74% |
The epidemiology of ALS: a conspiracy of genes, environment and time | 2013 | 37 | 83 | 63% |
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis | 2011 | 76 | 58 | 76% |
Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology | 2009 | 155 | 33 | 70% |
Controversies and priorities in amyotrophic lateral sclerosis | 2013 | 80 | 107 | 26% |
Amyotrophic lateral sclerosis | 2007 | 218 | 91 | 43% |
Prognostic factors in ALS: A critical review | 2009 | 109 | 90 | 79% |
The epidemiology of ALS and the role of population-based registries | 2006 | 78 | 60 | 80% |
Ethnic variation in the incidence of ALS - A systematic review | 2007 | 90 | 43 | 84% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ELEANOR LOU GEHRIG MDA ALS | 25 | 55% | 1.6% | 31 |
2 | ALS CLIN | 9 | 34% | 1.2% | 23 |
3 | TRAFFORD BIOMED | 9 | 52% | 0.6% | 12 |
4 | KINGS MND CARE | 9 | 67% | 0.4% | 8 |
5 | P TON MND CARE | 9 | 67% | 0.4% | 8 |
6 | SLA | 8 | 25% | 1.4% | 26 |
7 | FDN SERENA ONLUS | 6 | 41% | 0.6% | 12 |
8 | FORBES NORRIS MDA ALS | 6 | 53% | 0.4% | 8 |
9 | SLA PARIS | 6 | 100% | 0.2% | 4 |
10 | MOTOR NERVE CLIN | 4 | 67% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000224871 | PRIMARY LATERAL SCLEROSIS//BUNINA BODY//MOTOR NEURON DISEASE |
2 | 0.0000150489 | AMYOTROPHIC LATERAL SCLEROSIS//SOD1//ALS |
3 | 0.0000139322 | MECHANICAL INSUFFLATION EXSUFFLATION//PEAK COUGH FLOW//EXSUFFLATION |
4 | 0.0000112315 | SANATORIUM CHIBA//ALS TREATMENT//BRAIN CORTEX SYNAPTOSOMES |
5 | 0.0000079893 | MOTOR UNIT NUMBER ESTIMATION//QUANTITATIVE ELECTROMYOGRAPHY//MUNE |
6 | 0.0000078679 | DROOLING//SIALORRHEA//SIALORRHOEA |
7 | 0.0000071164 | TDP 43//C9ORF72//TARDBP |
8 | 0.0000061935 | BMAA//ALS PDC//BETA N METHYLAMINO L ALANINE |
9 | 0.0000055612 | HIRAYAMA DISEASE//BROWN VIALETTO VAN LAERE SYNDROME//MONOMELIC AMYOTROPHY |
10 | 0.0000052793 | RILUZOLE//2 CYCLOPROPYLIMINO 3 METHYL 1 3 THIAZOLINE HYDROCHLORIDE//ANTIGLUTAMATE |